160. Voices of CEO Excellence: Merck's Ken Frazier. Episode 2.

In this second episode of our Voices of CEO Excellence interview with Ken Frazier, the former executive chairman and CEO of Merck candidly reflects on how he managed past crises.

Frazier discusses his decision-making process around the litigation trial concerning Merck’s pain-relief drug Vioxx, and how his employees ensured that a potentially crippling cyber attack did not stop production of critical medicines. He also speaks about how his most important advisor, his wife Andrea, has kept him grounded. 

Frazier spoke with Vik Malhotra, former chairman of McKinsey’s Americas region and co-author of last year’s New York Times bestseller, CEO Excellence: The Six Mindsets That Distinguish the Best Leaders from the Rest and Steve Van Kuiken, a former leader in our Life Sciences Practice and global leader of McKinsey Technology. 

Listen to other episodes in our Voices of CEO Excellence series:

• Blackstone’s chairman, CEO, and cofounder, Stephen Schwarzman
• Morgan Stanley’s chairman and CEO, James Gorman

Join our LinkedIn community of more than 89,000 members and follow us on Twitter at @McKStrategy.

Explore our collection of Inside the Strategy Room episode transcripts on McKinsey.com

Take a masterclass with 67 of the world’s highest-performing CEOs and order your copy of the New York Times bestseller, CEO Excellence: The Six Mindsets That Distinguish the Best Leaders from the Rest.

Support the show: https://www.linkedin.com/showcase/mckinsey-strategy-&-corporate-finance/

See www.mckinsey.com/privacy-policy for privacy information